Syncor signs Israeli radiopharmacy deal
Radiopharmacy firm Syncor International of Woodland Hills, CA, has agreed to license its technology to Israeli nuclear research agency Soreq and its subsidiary, Isorad, which plan to establish a radiopharmacy in Israel. In exchange for providing
Radiopharmacy firm Syncor International of Woodland Hills, CA, has agreed to license its technology to Israeli nuclear research agency Soreq and its subsidiary, Isorad, which plan to establish a radiopharmacy in Israel. In exchange for providing information and technical assistance to set up the radiopharmacy, Syncor will receive quarterly payments. Soreq is affiliated with the Israel Atomic Energy Commission and carries out advanced R&D projects, while Isorad sells and markets Soreq products to private businesses.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
